Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00501 |
| Species: | Homo sapiens |
| Position : | chr17:32562334-32563183 |
| Year: | 2021 |
| Title: | Endothelial p300 promotes portal hypertension and hepatic fibrosis through CCL2-dependent macrophage recruitment |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 33351948 |
| MONDO: | |
| Tissue: | Liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | Liver sinusoidal endothelial cell |
| CVCL ID: | |
| Cell Type: | liver sinusoidal endothelial cell |
| Cell Ontology ID: | CL:1000413 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | CRISPR Knockout, CRISPRi, ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | CCL2 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|